Factor 7 helped Medical Interface Solutions secure key grants, strengthen its regulatory and commercial strategy, and access expert resources to drive funding readiness and market growth.

Factor 7 helped SweetBio refine its strategy, secure investors, and launch a scalable sales model—driving new revenue, stronger market positioning, and sustainable growth.

Factor 7 streamlined go-to-market efforts by targeting high-use neurology clinics, restructuring sales, and improving onboarding to boost adoption and reduce churn.